COMPLETED

Developing a Shared Decision Making Tool for Patients With Surgically Removed Non-small Cell Lung Cancer

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study observes conversations between non-small cell lung cancer patients and their doctors to support the development of a decision aid that can be used to inform discussions about treatment options for after surgery. Patients who have undergone surgery for their non-small cell lung cancer may have the option of completing additional treatment. Patients contemplating this additional treatment have been shown to be most satisfied with their choice if they perceive an effort by their doctor to share decision making. Shared decision making tools can help doctors guide conversations, offer tailored recommendations, and support deliberation on whether or not to pursue treatment. This study develops a shared decision making tool for patients with surgically removed non-small cell lung cancer contemplating additional treatment.

Official Title

The Development of a Shared Decision-Making Encounter Tool for Decisions of Adjuvant Treatment in Patients With Resected Non-Small Cell Lung Cancer

Quick Facts

Study Start:2022-02-17
Study Completion:2023-08-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT05416983

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * PATIENTS:
  2. * Adults \>= 18 years with biopsy proven resected non-small cell lung cancer (NSCLC)
  3. * Appointments to discuss adjuvant treatment of resected NSCLC
  4. * CLINICIANS:
  5. * Clinicians who meet with patients to discuss adjuvant treatment of resected NSCLC
  6. * PAG MEMBERS:
  7. * Adults \>= 18 years
  8. * Member of the Knowledge and Evaluation Research (KER) Unit Patient Advisory Group (PAG)
  1. * PATIENTS
  2. * Major barriers to providing informed consent (i.e., dementia, severe hearing or visual impairment)

Contacts and Locations

Principal Investigator

Konstantinos Leventakos, M.D.
PRINCIPAL_INVESTIGATOR
Mayo Clinic in Rochester

Study Locations (Sites)

Mayo Clinic in Rochester
Rochester, Minnesota, 55905
United States

Collaborators and Investigators

Sponsor: Mayo Clinic

  • Konstantinos Leventakos, M.D., PRINCIPAL_INVESTIGATOR, Mayo Clinic in Rochester

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-02-17
Study Completion Date2023-08-31

Study Record Updates

Study Start Date2022-02-17
Study Completion Date2023-08-31

Terms related to this study

Additional Relevant MeSH Terms

  • Lung Non-Small Cell Carcinoma